Regeneron Pharmaceuticals REGN Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's quick ratio?
- Regeneron Pharmaceuticals (REGN) reported quick ratio of 3× in Q1 2026.
- How has Regeneron Pharmaceuticals's quick ratio changed year-over-year?
- Regeneron Pharmaceuticals's quick ratio decreased by 26.6% year-over-year, from 4× to 3×.
- What is the long-term trend for Regeneron Pharmaceuticals's quick ratio?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's quick ratio has grown at a 5.4% compound annual growth rate (CAGR), from 11.7× to 14.5×.
- What does quick ratio mean?
- Can the company cover short-term bills without having to sell inventory first?
- How do you interpret quick ratio?
- More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
- How does quick ratio compare across companies?
- Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.